+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 55 Pages
  • June 2023
  • GlobalData
  • Kalbe Farma
  • ID: 1936307
PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Kalbe Farma Tbk (Kalbe) provides healthcare solutions to its customers. The company focuses on the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products, and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements, and over-the-counter (OTC) drugs, energy drinks, and various other preventive products. Kalbe is involved in the marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceutical products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, the Philippines, and Singapore. The company serves hospitals, pharmacies, and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk Key Recent Developments

Mar 05, 2023: Kalventis conduct the 2023 Indonesia Diabetes Leadership Summit with the Ministry of Health and PERKENI
Jan 16, 2023: Kalbe and its innovations, an effort to improve the pharmaceutical industry in Indonesia
Nov 28, 2022: Forsta Kalbe develop technology for the independence of local medical devices
Sep 30, 2022: Stem cell processing facility of Kalbe received a visit from the Ministry of Health, BPOM, BRIN, and KPSPS

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • PT Kalbe Farma Tbk - Key Facts
  • PT Kalbe Farma Tbk - Key Employees
  • PT Kalbe Farma Tbk - Major Products and Services
  • PT Kalbe Farma Tbk - History
  • PT Kalbe Farma Tbk - Company Statement
  • PT Kalbe Farma Tbk - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • PT Kalbe Farma Tbk - Business Description
  • Business Segment: Consumer Health
  • Overview
  • Performance
  • Business Segment: Distribution and Logistic
  • Overview
  • Performance
  • Business Segment: Nutritionals
  • Overview
  • Performance
  • Business Segment: Prescription Pharmaceuticals
  • Overview
  • Performance
  • Geographical Segment: Domestic
  • Performance
  • Geographical Segment: Export
  • Performance
  • R&D Overview
  • PT Kalbe Farma Tbk - Corporate Strategy
  • PT Kalbe Farma Tbk - SWOT Analysis
  • SWOT Analysis - Overview
  • PT Kalbe Farma Tbk - Strengths
  • PT Kalbe Farma Tbk - Weaknesses
  • PT Kalbe Farma Tbk - Opportunities
  • PT Kalbe Farma Tbk - Threats
  • PT Kalbe Farma Tbk - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • PT Kalbe Farma Tbk, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 05, 2023: Kalventis conduct the 2023 Indonesia Diabetes Leadership Summit with the Ministry of Health and PERKENI
  • Jan 16, 2023: Kalbe and its innovations, an effort to improve the pharmaceutical industry in Indonesia
  • Nov 28, 2022: Forsta Kalbe develop technology for the independence of local medical devices
  • Sep 30, 2022: Stem cell processing facility of Kalbe received a visit from the Ministry of Health, BPOM, BRIN, and KPSPS
  • Sep 19, 2022: Klikdokter collaborated witt GI Vita, increasing the AI-based health service
  • Aug 29, 2022: Monkeypox case found Indonesia, identify the symptoms
  • Jul 29, 2022: Kalbe's sales growth continues in second quarter 2022
  • Jul 16, 2022: The digital platform Mostrans optimized distribution and logistic services
  • Apr 22, 2022: Expanding services, KlikDokter conduct a strategic cooperation with WE+
  • Mar 31, 2022: Kalbe Booked Net Profit Growth of 16,5% in 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • PT Kalbe Farma Tbk, Key Facts
  • PT Kalbe Farma Tbk, Key Employees
  • PT Kalbe Farma Tbk, Major Products and Services
  • PT Kalbe Farma Tbk, History
  • PT Kalbe Farma Tbk, Other Locations
  • PT Kalbe Farma Tbk, Subsidiaries
  • PT Kalbe Farma Tbk, Joint Venture
  • PT Kalbe Farma Tbk, Key Competitors
  • PT Kalbe Farma Tbk, Ratios based on current share price
  • PT Kalbe Farma Tbk, Annual Ratios
  • PT Kalbe Farma Tbk, Interim Ratios
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • PT Kalbe Farma Tbk, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PT Kalbe Farma Tbk, Performance Chart (2018 - 2022)
  • PT Kalbe Farma Tbk, Ratio Charts
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • PT Darya-Varia Laboratoria Tbk
  • PT Dexa Medica
  • PT Eisai Indonesia
  • PT Infion
  • PT Prodia Widyahusada Tbk
  • PT Pyridam Farma Tbk
  • PT Sanbe Farma
  • PT Tempo Scan Pacific Tbk
  • PT. Millennium Pharmacon International TBK
  • PT. SOHO Industri Pharmasi